FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ranitidine Tablets
Status: Discontinuation
»Therapeutic Categories: Gastroenterology

Expand all

Sandoz (New 09/08/2017)

Company Contact Information:
800-525-8747

Presentation Posting Date Related Information
60 count container (NDC 0781-18-8360) 09/08/2017 Sandoz has made a business decision to permanently discontinue Ranitidine Tablets 150mg and 300mg. this decision was not related to efficacy, safety or quality.
1000 count container (NDC 0781-18-8310) 09/08/2017 Sandoz has made a business decision to permanently discontinue Ranitidine Tablets 150mg and 300mg. this decision was not related to efficacy, safety or quality.
30 count container (NDC 0781-18-8431) 09/08/2017 Sandoz has made a business decision to permanently discontinue Ranitidine Tablets 150mg and 300mg. this decision was not related to efficacy, safety or quality.
250 count container (NDC 0781-18-8425) 09/08/2017 Sandoz has made a business decision to permanently discontinue Ranitidine Tablets 150mg and 300mg. this decision was not related to efficacy, safety or quality.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English